About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

The State Council Information Office will hold a thematic briefing at 10:00 on July 21 as part of its "Kickoff for the 15th Five-Year" series. Vice Minister of Transport Xu Chengguang and leaders from the National Railway Administration, Civil Aviati

2026-07-16

The State Council Information Office will hold a thematic briefing at 10:00 on July 21 as part of its "Kickoff for the 15th Five-Year" series. Vice Minister of Transport Xu Chengguang and leaders from the National Railway Administration, Civil Aviation Administration of China and the State Post Bureau will outline plans to accelerate building a transportation powerhouse and to improve a modern integrated transport system, and will field questions.

Other News
2026-07-16

The U.S. House voted 314-104 to reject an amendment that would have barred roughly $3.3 bln in military aid to Israel. The measure drew support from 103 of 212 House Democrats, reflecting ongoing divisions within the party; only one Republican, Kentu

The U.S. House voted 314-104 to reject an amendment that would have barred roughly $3.3 bln in military aid to Israel. The measure drew support from 103 of 212 House Democrats, reflecting ongoing divisions within the party; only one Republican, Kentucky Representative Thomas Massie, voted in favor.
2026-07-16

China’s National Healthcare Security Administration said the reporting window for the 12th batch of national centralized volume-based drug procurement closes on the afternoon of July 16. As of 12:00 on July 16, about 45,000 medical institutions had s

China’s National Healthcare Security Administration said the reporting window for the 12th batch of national centralized volume-based drug procurement closes on the afternoon of July 16. As of 12:00 on July 16, about 45,000 medical institutions had submitted procurement demand covering 65 products and more than 530 pharmaceutical companies. Average bidders per product stood at 15; five products had over 30 participating firms and the maximum was 54 for a single product. NHSA asked remaining institutions to complete reporting and urged pharmaceutical companies to prepare bids and price rationally based on cost and market competition.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.